Business Description
Tandem Diabetes Care Inc
NAICS : 339112
SIC : 3841
ISIN : US8753722037
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.95 | |||||
Equity-to-Asset | 0.25 | |||||
Debt-to-Equity | 2.04 | |||||
Debt-to-EBITDA | -4.47 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 1.9 | |||||
Beneish M-Score | -2.62 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.1 | |||||
3-Year EBITDA Growth Rate | -138.3 | |||||
3-Year EPS without NRI Growth Rate | -103.1 | |||||
3-Year FCF Growth Rate | -117.4 | |||||
3-Year Book Growth Rate | -6.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 34.01 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 13.96 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.2 | |||||
9-Day RSI | 48.72 | |||||
14-Day RSI | 49.48 | |||||
6-1 Month Momentum % | 52.23 | |||||
12-1 Month Momentum % | 89.85 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.05 | |||||
Quick Ratio | 2.38 | |||||
Cash Ratio | 1.88 | |||||
Days Inventory | 137.65 | |||||
Days Sales Outstanding | 45.46 | |||||
Days Payable | 44.78 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.7 | |||||
Shareholder Yield % | 0.12 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 49.06 | |||||
Operating Margin % | -17.47 | |||||
Net Margin % | -17.15 | |||||
FCF Margin % | -8.03 | |||||
ROE % | -47.6 | |||||
ROA % | -14.47 | |||||
ROIC % | -35.93 | |||||
3-Year ROIIC % | -69.58 | |||||
ROC (Joel Greenblatt) % | -46.96 | |||||
ROCE % | -16.51 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 3.49 | |||||
PB Ratio | 11.93 | |||||
Price-to-Tangible-Book | 11.94 | |||||
EV-to-EBIT | -22.89 | |||||
EV-to-Forward-EBIT | -35.46 | |||||
EV-to-EBITDA | -26.36 | |||||
EV-to-Forward-EBITDA | 66.39 | |||||
EV-to-Revenue | 3.54 | |||||
EV-to-Forward-Revenue | 2.8 | |||||
EV-to-FCF | -43.84 | |||||
Price-to-Projected-FCF | 14.14 | |||||
Price-to-Median-PS-Value | 0.76 | |||||
Price-to-Net-Current-Asset-Value | 95.83 | |||||
Earnings Yield (Greenblatt) % | -4.37 | |||||
FCF Yield % | -2.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Tandem Diabetes Care Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 736.884 | ||
EPS (TTM) (€) | -1.935 | ||
Beta | 3 | ||
Volatility % | 91.77 | ||
14-Day RSI | 49.48 | ||
14-Day ATR (€) | 1.294935 | ||
20-Day SMA (€) | 38.721 | ||
12-1 Month Momentum % | 89.85 | ||
52-Week Range (€) | 13.19 - 48.96 | ||
Shares Outstanding (Mil) | 65.46 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Tandem Diabetes Care Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Tandem Diabetes Care Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Tandem Diabetes Care Inc Frequently Asked Questions
What is Tandem Diabetes Care Inc(STU:TD5A)'s stock price today?
When is next earnings date of Tandem Diabetes Care Inc(STU:TD5A)?
Does Tandem Diabetes Care Inc(STU:TD5A) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |